Pacific Biosciences of California PACB Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's financing cash flow?
- Pacific Biosciences of California (PACB) reported financing cash flow of $1.44M in Q1 2026.
- How has Pacific Biosciences of California's financing cash flow changed year-over-year?
- Pacific Biosciences of California's financing cash flow decreased by 26.6% year-over-year, from $1.96M to $1.44M.
- What is the long-term trend for Pacific Biosciences of California's financing cash flow?
- Over 2 years (2021 to 2024), Pacific Biosciences of California's financing cash flow has grown at a -80.8% compound annual growth rate (CAGR), from $1.17B to -$42.99M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.